Biodistribution of injected tritiated hyaluronic acid in mice: A comparison between macromolecules and hyaluronic acid-derived oligosaccharides

In Vivo

Volumn 18, Issue 2, 2004, Pages 181-188

  Courel, Mare Noelle ^a   Maingonnat, Catherine ^a   Bertrand, Philippe ^a   Chauzy, Claude ^a   Smadja Joffe, Florence ^b   Delpech, Bertrand ^a  

^a CENTRE HENRI BECQUEREL   (France)

^b SAINT LOUIS HOSPITAL   (France)

Author keywords

Bone marrow; Hyaluronan; Quantitation; Tissue extract; Tritiated oligosacchride size

Indexed keywords

HYALURONIC ACID; HYALURONIC ACID DERIVATIVE; OLIGOSACCHARIDE; TRITIUM;

ACUTE GRANULOCYTIC LEUKEMIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW; CELL DIFFERENTIATION; CELL PROLIFERATION; CHROMATOGRAPHY; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG MANUFACTURE; DRUG RECEPTOR BINDING; DRUG TISSUE LEVEL; FEMALE; MACROMOLECULE; MOUSE; NONHUMAN;

EID: 1842841705     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Laurent TC and Fraser JRE: Hyaluronan. FASEB J 6: 2397-2404, 1992.
2. Fraser JRE, Laurent TC and Laurent UBG: Hyaluronan: its nature, distribution, functions and turnover. J Int Med 242: 27-33, 1997.
3. West DC, Hampson IN, Arnold F and Kumar S: Angiogenesis induced by degradation products of hyaluronic acid. Science 228: 1324-1326, 1985.
4. West DC and Kumar S: The effect of hyaluronate and its oligosaccharides on endothelial cell proliferation and monolayer integrity. Exp Cell Res 183: 179-196,1989.
5. Lees VC, Fan TPD and West DC: Angiogenesis in a delayed revascularization model is accelerated by angiogenic oligosaccharides of hyaluronan. Lab Inves 73: 259-266,1995.
6. Trochon V, Mabilat C, Bertrand P, Legrand Y, Smadja-Joffe F, Soria C, Delpech B and He Lu: Evidence of involvement of CD44 in endothelial cell proliferation, migration and angiogenesis in vitro. Int J Cancer 66: 664-668,1996.
7. Zeng C, Toole BP, Kinney SD, Kuo JW and Stamenkovic I: Inhibition of tumor growth in vivo by hyaluronan oligomers. Int J Cancer 77: 396-401,1998.
8. Herrera-Gayol A and Jothy S: Effect of hyaluronan on xenotransplanted breast cancer. Exp Mol Pathol 72: 179-185, 2002.
9. Coradini D, Pellizzaro C, Miglierini G, Daidone MG and Perbellini A: Hyaluronic acid as drug delivery for sodium butyrate: improvement of the anti-proliferative activity on breast-cancer cell line. Int J Cancer 81: 411-416,1999.
10. Charrad RS, Li Y, Delpech B, Balitrand N, Clay D, Jasmin C, Chomienne C and Smadja-Joffe F: Ligation of the CD44 adhesion molecule reverses blockage of differentiation in human acute myeloid leukemia. Nature Med 5: 669-676,1999.
11. Fraser JRE, Laurent TC, Pertoft H and Baxter E: Plasma clearance, tissue distribution and metabolism of hyaluronic acid injected intravenously in the rabbit. Biochem J 200: 415-424, 1981.
12. Fraser JRE, Appelgren LE and Laurent TC: Tissue uptake of circulating hyaluronic acid. A whole body autoradiographic study. Cell Tissue Res 233: 285-293, 1983.
13. Fraser JRE, Alcorn D, Laurent TC, Robinson AD and Ryan GB: Uptake of circulating hyaluronic acid by the rat liver. Cellular localization in situ. Cell Tissue Res 242: 505-510, 1985.
14. Banerji S, Ni J, Wang SX, Clasper S, Su J, Tammi R, Jones M and Jackson DG: LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J Cell Biol 144: 789-801, 1999.
15. Prevo R, Banerji S, Ferguson DJP, Clasper S and Jackson DG: Mouse LYVE-1 is an endocytic receptor for hyaluronan in lymphatic endothelium. J Biol Chem 276: 19420-19430, 2001.
16. Delpech B, Courel MN, Maingonnat C, Chauzy C, Sesboue R and Pratesi G: Hyaluronan digestion and synthesis in an experimental model of metastasic tumour. Histochem J 33: 553-558, 2001.
17. Delpech B, Bertrand P, Maingonnat C, Girard N and Chauzy C: Enzyme-linked hyaluronectin: a unique reagent for hyaluronan assay and tissue location and for hyaluronidase activity detection. Anal Biochem 229: 35-41, 1995.
18. Courel MN, Maingonnat C, Tranchepain F, Deschrevel B, Vincent JC, Bertrand P and Delpech B: Importance of hyaluronan length in a hyaladherin-based assay for hyaluronan. Anal Biochem 302: 285-290, 2002.
19. Bitter T and Muir HM: A modified uronic acid carbazole reaction. Anal Biochem 4: 330-334, 1962.
20. Reissig JL, Strominger JL and Leloir LF: A modified colorimetric method for the estimation of N-acetyl-amino sugars. J Biol Chem 217: 959-966, 1955.
21. Laurent TC, Fraser JRE, Pertoft H and Smedsrod B: Binding of hyaluronate and chondroitin sulphate to liver endothelial cells. Biochem J 234: 653-658, 1986.
22. Tengblad A, Laurent UBG, Lilja K, Cahill RNP, Engstrom-Laurent A, Fraser JRE, Hansson HE and Laurent TC: Concentration and relative molecular mass of hyaluronate in lymph and blood. Biochem J 236: 521-525, 1986.
23. Fraser JRE, Brown TJ and Laurent TC: Catabolism of hyaluronan. In: Laurent TC, ed. The Chemistry, Biology and Medical Applications of Hyaluronan and Its Derivatives vol 72, London and Miami, Portland Press, 85-92, 1998.
24. Underhill CB, Chi-Rosso G and Toole BP: Effects of detergent solubilization on the hyaluronate-binding protein from membranes of Simian Virus 40-transformed 3T3 cells. J Biol Chem 258: 8086-8091, 1983.
25. Tammi R, Mac Callum D, Hascall VC, Pienimaki JP, Hyttinen M and Tammi M: Hyaluronan bound to CD44 on keratinocytes is displaced by hyaluronan decasaccharides and not hexasaccharides. J Biol Chem 273: 28878-28888, 1998.